Serono Serostim Distribution Program To Help Reconcile Medicaid Rebates
Executive Summary
Serono's limited distribution program for the AIDS wasting treatment Serostim will help the company reconcile its rebate payments to state Medicaid programs
You may also be interested in...
California Track-and-Trace Law Is Good Model, EMD Serono Says
The company has been tracking shipments of its growth hormone agent Serostim since 2002 to forestall counterfeiting and fraudulent claims and backed a full track-and-trace system during a forum sponsored by Pew Health Group. But while the system makes good business sense for a specialty firm, the acknowledgement could complicate the existing political picture for industry.
Serono Zorbtive (hGH) For Short Bowel Syndrome Clears FDA; Launch In 2004
Serono will launch Zorbtive (somatropin) for the treatment of short bowel syndrome with a physician education program intended to ensure proper disease management for patients taking the growth hormone
Serono Zorbtive (hGH) For Short Bowel Syndrome Clears FDA; Launch In 2004
Serono will launch Zorbtive (somatropin) for the treatment of short bowel syndrome with a physician education program intended to ensure proper disease management for patients taking the growth hormone